Matches in Nanopublications for { ?s ?p "DDI between Fosamprenavir and Lurasidone - Concomitant therapy with a strong CYP3A4 inhibitor will increase level or effect of lurasidone. Coadministration with lurasidone is contraindicated. [drugbank_resource:DB01319_DB08815]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.